These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 17547312)

  • 21. Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache.
    Haas DC; Sheehe PR
    Headache; 2004; 44(10):1029-37. PubMed ID: 15546268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M; Silva S; Cottrell C
    Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study.
    Evers S; Vollmer-Haase J; Schwaag S; Rahmann A; Husstedt IW; Frese A
    Cephalalgia; 2004 Oct; 24(10):838-43. PubMed ID: 15377314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of biofeedback in the treatment of migraine and tension type headaches.
    Mullally WJ; Hall K; Goldstein R
    Pain Physician; 2009; 12(6):1005-11. PubMed ID: 19935987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
    Silberstein SD; Blumenfeld AM; Cady RK; Turner IM; Lipton RB; Diener HC; Aurora SK; Sirimanne M; DeGryse RE; Turkel CC; Dodick DW
    J Neurol Sci; 2013 Aug; 331(1-2):48-56. PubMed ID: 23790235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
    Schulte-Mattler WJ; Krack P;
    Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
    Lew HL; Lee EH; Castaneda A; Klima R; Date E
    Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases.
    Tepper SJ; Bigal ME; Sheftell FD; Rapoport AM
    Headache; 2004 Sep; 44(8):794-800. PubMed ID: 15330826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
    Donaldson D; Sundermann R; Jackson R; Bastani A
    Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acupuncture in migraine prevention: a randomized sham controlled study with 6-months posttreatment follow-up.
    Alecrim-Andrade J; Maciel-Júnior JA; Carnè X; Severino Vasconcelos GM; Correa-Filho HR
    Clin J Pain; 2008 Feb; 24(2):98-105. PubMed ID: 18209514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin type A for the treatment of nummular headache: four case studies.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Mar; 48(3):442-7. PubMed ID: 18028377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of an intensive multidisciplinary headache treatment program.
    Gunreben-Stempfle B; Griessinger N; Lang E; Muehlhans B; Sittl R; Ulrich K
    Headache; 2009 Jul; 49(7):990-1000. PubMed ID: 19473281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of migraine headache with botulinum toxin type A.
    Binder WJ; Blitzer A
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):465-75. PubMed ID: 15062251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Headache prevention outcome and body mass index.
    Bigal ME; Gironda M; Tepper SJ; Feleppa M; Rapoport AM; Sheftell FD; Lipton RB
    Cephalalgia; 2006 Apr; 26(4):445-50. PubMed ID: 16556246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
    Miller D; Richardson D; Eisa M; Bajwa RJ; Jabbari B
    Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study.
    Smuts JA; Schultz D; Barnard A
    Headache; 2004 Sep; 44(8):801-5. PubMed ID: 15330827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A; Barnes M; Comiskey C
    Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
    Dodick D; Blumenfeld A; Silberstein SD
    Clin Dermatol; 2004; 22(1):76-81. PubMed ID: 15158549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine.
    Magalhães E; Menezes C; Cardeal M; Melo A
    Clin Neurol Neurosurg; 2010 Jul; 112(6):463-6. PubMed ID: 20399553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.